CanBiotech Will Showcase A Novel Diagnostic And Prognostic Test For Diffuse, Large B-Cell Lymphoma (DLBCL) At The American Society of Hematology Annual Meeting In New Orleans
Published: Nov 25, 2013
RUTHERFORD, N.J., Nov. 25, 2013 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based diagnostics, is presenting data from its research collaboration with Memorial Sloan-Kettering Cancer Center ("MSKCC") at the American Society of Hematology ("ASH") 55th Annual Meeting and Exposition.
Help employers find you! Check out all the jobs and post your resume.